Potentiation of IL-19 expression in airway epithelia by IL-17A and IL-4/IL-13: Important implications in asthma

Journal of Allergy and Clinical Immunology

Volumn 121, Issue 6, 2008, Pages

  Huang, Fei ^a   Wachi, Shinichiro ^a   Thai, Philip ^a   Loukoianov, Artem ^a   Tan, Kin Hup ^a   Forteza, Rosanna Malbran ^b   Wu, Reen ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

airway epithelium; asthma; IL 13; IL 17A; IL 19; IL 4; nuclear factor B; signal transducer and activator of transcription 6; TH2 cytokine

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 19; INTERLEUKIN 4; SMALL INTERFERING RNA; STAT6 PROTEIN;

ADULT; AGED; ARTICLE; ASTHMA; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GENE CONTROL; GENE EXPRESSION; HUMAN; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM; TH2 CELL; TRANSCRIPTION REGULATION; UPREGULATION;

EID: 44649131954     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.04.016     Document Type: Article

References (42)

1. Gallagher G., Dickensheets H., Eskdale J., Izotova L.S., Mirochnitchenko O.V., Peat J.D., et al. Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10). Genes Immun 1 (2000) 442-450
2. Andoh A., Zhang Z., Inatomi O., Fujino S., Deguchi Y., Araki Y., et al. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 129 (2005) 969-984
3. Conti P., Kempuraj D., Frydas S., Kandere K., Boucher W., Letourneau R., et al. IL-10 subfamily members: IL-19, IL-20, IL-22, IL-24 and IL-26. Immunol Lett 88 (2003) 171-174
4. Chang C., Magracheva E., Kozlov S., Fong S., Tobin G., Kotenko S., et al. Crystal structure of interleukin-19 defines a new subfamily of helical cytokines. J Biol Chem 278 (2003) 3308-3313
5. Boniface K., Bernard F.X., Garcia M., Gurney A.L., Lecron J.C., and Morel F. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol 174 (2005) 3695-3702
6. Sa S.M., Valdez P.A., Wu J., Jung K., Zhong F., Hall L., et al. The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis. J Immunol 178 (2007) 2229-2240
7. Liao Y.C., Liang W.G., Chen F.W., Hsu J.H., Yang J.J., and Chang M.S. IL-19 induces production of IL-6 and TNF-alpha and results in cell apoptosis through TNF-alpha. J Immunol 169 (2002) 4288-4297
8. Koks S., Kingo K., Vabrit K., Ratsep R., Karelson M., Silm H., et al. Possible relations between the polymorphisms of the cytokines IL-19, IL-20 and IL-24 and plaque-type psoriasis. Genes Immun 6 (2005) 407-415
9. Koks S., Kingo K., Ratsep R., Karelson M., Silm H., and Vasar E. Combined haplotype analysis of the interleukin-19 and -20 genes: relationship to plaque-type psoriasis. Genes Immun 5 (2004) 662-667
10. Romer J., Hasselager E., Norby P.L., Steiniche T., Thorn Clausen J., and Kragballe K. Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine a or calcipotriol. J Invest Dermatol 121 (2003) 1306-1311
11. Liao S.C., Cheng Y.C., Wang Y.C., Wang C.W., Yang S.M., Yu C.K., et al. IL-19 induced Th2 cytokines and was up-regulated in asthma patients. J Immunol 173 (2004) 6712-6718
12. Hsing C.H., Hsu C.C., Chen W.Y., Chang L.Y., Hwang J.C., and Chang M.S. Expression of IL-19 correlates with Th2 cytokines in uraemic patients. Nephrol Dial Transplant 22 (2007) 2230-2238
13. Gallagher G., Eskdale J., Jordan W., Peat J., Campbell J., Boniotto M., et al. Human interleukin-19 and its receptor: a potential role in the induction of Th2 responses. Int Immunopharmacol 4 (2004) 615-626
14. Otkjaer K., Kragballe K., Funding A.T., Clausen J.T., Noerby P.L., Steiniche T., et al. The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis. Br J Dermatol 153 (2005) 911-918
15. Li H.H., Lin Y.C., Chen P.J., Hsiao C.H., Lee J.Y., Chen W.C., et al. Interleukin-19 upregulates keratinocyte growth factor and is associated with psoriasis. Br J Dermatol 153 (2005) 591-595
16. Boniface K., Lecron J.C., Bernard F.X., Dagregorio G., Guillet G., Nau F., et al. Keratinocytes as targets for interleukin-10-related cytokines: a putative role in the pathogenesis of psoriasis. Eur Cytokine Netw 16 (2005) 309-319
17. Zhong H., Wu Y., Belardinelli L., and Zeng D. A2B adenosine receptors induce IL-19 from bronchial epithelial cells, resulting in TNF-alpha increase. Am J Respir Cell Mol Biol 35 (2006) 587-592
18. Molet S., Hamid Q., Davoine F., Nutku E., Taha R., Page N., et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 108 (2001) 430-438
19. Huang F., Kao C.Y., Wachi S., Thai P., Ryu J.S., and Wu R. Requirement for both JAK-mediated PI3K signaling and ACT1/TRAF6/TAK1-dependent NF-B Activation by IL-17A in enhancing cytokine expression in human airway epithelia cells. J Immunol 179 (2007) 6504-6513
20. Wu R., Yankaskas J., Cheng E., Knowles M.R., and Boucher R. Growth and differentiation of human nasal epithelial cells in culture. Serum-free, hormone-supplemented medium and proteoglycan synthesis. Am Rev Respir Dis 132 (1985) 311-320
21. Wu R., Martin W.R., Robinson C.B., St George J.A., Plopper C.G., Kurland G., et al. Expression of mucin synthesis and secretion in human tracheobronchial epithelial cells grown in culture. Am J Respir Cell Mol Biol 3 (1990) 467-478
22. Kao C.Y., Huang F., Chen Y., Thai P., Wachi S., Kim C., et al. Up-regulation of CC chemokine ligand 20 expression in human airway epithelium by IL-17 through a JAK-independent but MEK/NF-kappaB-dependent signaling pathway. J Immunol 175 (2005) 6676-6685
23. Kao C.Y., Chen Y., Thai P., Wachi S., Huang F., Kim C., et al. IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways. J Immunol 173 (2004) 3482-3491
24. Wachi S., Yoneda K., and Wu R. Interactome-transcriptome analysis reveals the high centrality of genes differentially expressed in lung cancer tissues. Bioinformatics 21 (2005) 4205-4208
25. Chen Y., Thai P., Zhao Y.H., Ho Y.S., DeSouza M.M., and Wu R. Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J Biol Chem 278 (2003) 17036-17043
26. Takeda K., Kamanaka M., Tanaka T., Kishimoto T., and Akira S. Impaired IL-13-mediated functions of macrophages in STAT6-Deficient mice. J Immunol 157 (1996) 3220-3222
27. McAllister F., Henry A., Kreindler J.L., Dubin P.J., Ulrich L., Steele C., et al. Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis. J Immunol 175 (2005) 404-412
28. Bullens D.M., Truyen E., Coteur L., Dilissen E., Hellings P.W., Dupont L.J., et al. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx?. Respir Res 7 (2006) 135
29. Chakir J., Shannon J., Molet S., Fukakusa M., Elias J., Laviolette M., et al. Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. J Allergy Clin Immunol 111 (2003) 1293-1298
30. Linden A. Role of interleukin-17 and the neutrophil in asthma. Int Arch Allergy Immunol 126 (2001) 179-184
31. Linden A., Hoshino H., and Laan M. Airway neutrophils and interleukin-17. Eur Respir J 15 (2000) 973-977
32. Huang S.K., Xiao H.Q., Kleine-Tebbe J., Paciotti G., Marsh D.G., Lichtenstein L.M., et al. IL-13 expression at the sites of allergen challenge in patients with asthma. J Immunol 155 (1995) 2688-2694
33. Doucet C., Brouty-Boye D., Pottin-Clemenceau C., Canonica G.W., Jasmin C., and Azzarone B. Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma. J Clin Invest 101 (1998) 2129-2139
34. Humbert M., Durham S.R., Kimmitt P., Powell N., Assoufi B., Pfister R., et al. Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma. J Allergy Clin Immunol 99 (1997) 657-665
35. Zhu Z., Homer R.J., Wang Z., Chen Q., Geba G.P., Wang J., et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 103 (1999) 779-788
36. Li L., Xia Y., Nguyen A., Lai Y.H., Feng L., Mosmann T.R., et al. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J Immunol 162 (1999) 2477-2487
37. Wong C.K., Ho C.Y., Ko F.W., Chan C.H., Ho A.S., Hui D.S., et al. Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-gamma, IL-4, IL-10 and IL-13) in patients with allergic asthma. Clin Exp Immunol 125 (2001) 177-183
38. Barczyk A., Pierzchala W., and Sozanska E. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir Med 97 (2003) 726-733
39. Hellings P.W., Kasran A., Liu Z., Vandekerckhove P., Wuyts A., Overbergh L., et al. Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am J Respir Cell Mol Biol 28 (2003) 42-50
40. Prause O., Laan M., Lotvall J., and Linden A. Pharmacological modulation of interleukin-17-induced GCP-2-, GRO-alpha- and interleukin-8 release in human bronchial epithelial cells. Eur J Pharmacol 462 (2003) 193-198
41. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6 (2005) 1133-1141
42. Cai L., Suboc P., Hogue D.A., Fei D.T., and Filvaroff E.H. Interleukin 17 induced nitric oxide suppresses matrix synthesis and protects cartilage from matrix breakdown. J Rheumatol 29 (2002) 1725-1736